The cationic cyclen based Eu(III)-phen conjugated 1.Eu was synthesised as a chemosensor for Cu(II), where the recognition in water at pH 7.4 gave rise to quenching of the Eu(III) luminescence and the formation of tetranuclear polymetallic Cu(II)-Eu(III) macrocyclic complexes in solution where Cu(II) was bound by three 1.Eu conjugates.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1039/b316176e | DOI Listing |
Dalton Trans
January 2025
Department of Human Sciences for the Promotion of Quality of Life, Università San Raffaele Roma, via di Val Cannuta 247, 00166 Roma, Italy.
Angew Chem Int Ed Engl
January 2025
Institute of Chemistry, CAS, Laboratory of Colloid and Interface Scie, Zhong Guancun, 100080, Beijing, CHINA.
Here, we report the synthesis and self-assembly of a novel chiral 2,3:6,7‒naphthalenediimide-based triangular macrocycle (NDI-∆) and their chiroptical properties. The enantiomeric NDI-∆ is synthesized by condensation of (RR) or (SS)-trans-1,2-cyclohexanediamine and 2,3,6,7-naphthalenetetracarboxylic 2,3:6,7-dianhydride, in which the chirality of the macrocycles is controlled by the diamine. With the rigid outer π-surface, the macrocycle showed unique chiroptical properties and self-assembly modes.
View Article and Find Full Text PDFJ Org Chem
December 2024
Aix-Marseille Université, CNRS UMR 7325 Centre Interdisciplinaire de Nanoscience de Marseille (CINaM), Campus de Luminy, Marseille cedex 09 13288, France.
The one-pot transamination reactions on a zwitterionic benzoquinonemonoimine yield either a quinoxaline derivative or bis-zwitterionic macrocycles, depending on the number of carbon atoms bridging primary polyamines. These latter products, featuring two confined donor cavities, are the result of a [2 + 2] condensation without the need for template effect or high dilution conditions.
View Article and Find Full Text PDFJACS Au
December 2024
State Key Laboratory of Chemical Biology, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, No. 345 Lingling Road, Shanghai 200032, China.
Macrocyclization is a compelling strategy for conventional drug design for improving biological activity, target specificity, and metabolic stability, but it was rarely applied to the design of PROTACs possibly due to the mechanism and structural complexity. Herein, we report the rational design of the first series of "Head-to-Tail" macrocyclic PROTACs. The resulting molecule exhibited pronounced Brd4 protein degradation with low nM DC values while almost totally dismissing the "hook effect", which is a general character and common concern of a PROTAC, in multiple cancer cell lines.
View Article and Find Full Text PDFInvest Radiol
October 2024
From the Research and Innovation Department, Guerbet, Roissy, France (I.M., M.-C.D.G., J.-F.M., A.D., Y.B., N.D., I.S., G.B., C.M., C.F., O.R., S.C.); General, Organic, and Biomedical Chemistry Unit, NMR and Molecular Imaging Laboratory, University of Mons, Mons, Belgium (C.H., S.L.); and Institute of Inorganic and Analytical Chemistry, University of Münster, Münster, Germany (C.K., T.J.M., U.K.).
Objectives: Gadopiclenol is a q = 2 pyclen gadolinium-based contrast agent (GBCA) recently approved by the Food and Drug Administration, European Medicines Agency, and other European countries. The aim of this report is to demonstrate its stability in multiple stressed in vitro conditions and in vivo, in rat kidney, while maintaining its higher relaxivity compared with conventional GBCAs on the market.
Materials And Methods: Both gadopiclenol and its chemical precursor Pi828-Gd were characterized and compared with q = 1 gadolinium (Gd) complexes.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!